The U.S. Federal Trade Commission is reportedly investigating 190 pharmaceutical companies for allegedly interfering with the ability of generic drug manufacturers to compete.
The U.S. Federal Trade Commission is reportedly investigating 190 pharmaceutical companies for allegedly interfering with the ability of generic drug manufacturers to compete.
